Shares of Liberty Biopharma Inc (CVE:LTY – Get Free Report) passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of C$2.00 and traded as high as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares changing hands.
Liberty Biopharma Price Performance
The company has a market capitalization of C$21.54 million and a P/E ratio of -12.66. The business’s 50-day moving average is C$2.00 and its two-hundred day moving average is C$2.00. The company has a quick ratio of 0.12, a current ratio of 0.12 and a debt-to-equity ratio of 8.19.
About Liberty Biopharma
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
Featured Articles
- Five stocks we like better than Liberty Biopharma
- How to Invest in Small Cap StocksĀ
- Charles Schwab Fortifies its Uptrend on EPS Beat
- Trading Stocks: RSI and Why it’s Useful
- Lockheed Martin Stock Aims for a Fresh All-Time High
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.